EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
    3.1.2.12 | Retinoblastoma |
3346019 |
A "new" allele of esterase D in a retinoblastoma family. |
therapeutic application
unassigned |
3
0 |
| 3.1.2.12 | Retinoblastoma |
3864729 |
A case report of a patient with retinoblastoma and chromosome 13q deletion: assignment of a new gene (gene for LCP1) on human chromosome 13. |
unassigned |
0 |
| 3.1.2.12 | Retinoblastoma |
3472646 |
A chromosomal breakpoint that separates the esterase D and retinoblastoma predisposition loci in a patient with del(13)(q14q31). |
unassigned |
0 |
| 3.1.2.12 | Retinoblastoma |
1819032 |
A genetic study of retinoblastoma. |
diagnostic usage
ongoing research
unassigned |
4
3
0 |
| 3.1.2.12 | Glioblastoma |
2838156 |
A human glioblastoma line with karyotypic nullisomy 13 containing several chromosome 13-specific sequences. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 3.1.2.12 | Neoplasms |
3471703 |
A null allele of esterase D is a marker for genetic events in retinoblastoma formation. |
diagnostic usage
ongoing research
unassigned |
1
3
0 |
| 3.1.2.12 | Retinoblastoma |
3471703 |
A null allele of esterase D is a marker for genetic events in retinoblastoma formation. |
diagnostic usage
ongoing research
unassigned |
1
3
0 |
| 3.1.2.12 | Agranulocytosis |
10503166 |
A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial. |
causal interaction
therapeutic application
unassigned |
1
2
0 |
| 3.1.2.12 | Anaphylaxis |
10503166 |
A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial. |
causal interaction
therapeutic application
unassigned |
1
2
0 |
| 3.1.2.12 | Hepatolenticular Degeneration |
3456572 |
A sialic acid-specific O-acetylesterase in human erythrocytes: possible identity with esterase D, the genetic marker of retinoblastomas and Wilson disease. |
diagnostic usage
ongoing research
unassigned |
1
2
0 |
